← Back to ETON

Eton Pharmaceuticals, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 14/05/2026Sep 2025Filed 06/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 14/05/2026Sep 2024Filed 06/11/2025Jun 2024Filed 07/08/2025Mar 2024Filed 13/05/2025
$38$24$22$19$17$10$9.1$8
$12$1.6−$1.9−$2.6−$1.6$0.6−$3−$0.8
$0.35$0.05−$0.07−$0.10−$0.06$0.02−$0.12−$0.03
333227272727

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.